Search

everythinglearnresearchcommunity

for

Search:↓

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

Some people with severe, long-lasting baldness responded well to a specific combination treatment.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Low-dose oral isotretinoin improved hair loss and facial bumps in patients with a specific type of hair loss.

The fractional carbon dioxide laser is a safe and effective treatment for alopecia areata and works better than betamethasone valerate cream alone.

Platelet-Rich Plasma treatment helps hair regrowth in people with mild Alopecia Areata, improving their quality of life with minimal side effects.

Oral Apremilast effectively treats alopecia areata in most patients.

Topical clobetasol propionate 0.05% ointment is more effective in promoting hair regrowth in patients with alopecia areata than topical tacrolimus 0.1% ointment.

The combination of laser and topical steroids is more effective for treating alopecia areata than topical steroids alone.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Photobiomodulation therapy may speed up hair regrowth after chemotherapy in the short term.

The document concludes that assessing hair follicle damage due to cyclophosphamide in mice involves analyzing structural changes and suggests a scoring system for standardized evaluation.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Baricitinib is effective and safe for treating severe alopecia areata.

RTA 408 cream protects mice from radiation skin damage.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Carboxytherapy may help increase hair growth in alopecia patients but requires ongoing treatment.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Corticosteroids worked better than anthralin cream for hair regrowth.

Spironolactone is a low-cost, effective, and generally safe treatment for various skin conditions related to hormones.